Clinical Trials Browser

Phase 2 × Terminated × midostaurin × Clear all

NCT03951961 2022-01-21

Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute